(Q34913813)

5 August 2017

1 reference

title

Dendritic cells in vaccination therapies of malignant diseases (English)

1 reference

5 August 2017

Peter Brossart

1

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Transfusion and Apheresis Science

5 August 2017

published in

1 reference

5 August 2017

volume

27

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

183-186

1 reference

Dendritic cells and the control of immunity

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Origin, maturation and antigen presenting function of dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900041-1

7 January 2021

10.1016/S1473-0502(02)00041-1

Identifiers

DOI

1 reference

5 August 2017

1 reference